Pfizer Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Pfizer Inc.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
/ 
Pfizer Inc. (PFE) is an American multinational pharmaceutical and biotechnology company headquartered in New York, United States. Founded in 1849, Pfizer is one of the world’s largest drugmakers, focused on the discovery, development, and manufacture of medicines and vaccines.
The company’s portfolio spans therapeutic areas including oncology, immunology, cardiology, endocrinology, and rare diseases. Pfizer is also a major producer of vaccines for infectious diseases and has played a prominent role in advancing mRNA-based therapies through its collaboration with BioNTech.
Pfizer operates research, development, and manufacturing facilities worldwide, with a strong commercial presence across North America, Europe, and Asia-Pacific. The group continues to invest in biotechnology, next-generation vaccines, and treatments to address global healthcare needs.
Pfizer Inc. is listed on the New York Stock Exchange (NYSE).
Saxo provides this content for general information only. It is not intended as personal advice, an offer, or a recommendation. Saxo does not guarantee accuracy or completeness and accepts no liability for losses. Consider obtaining independent advice before any investment decision.